New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 2 years, 2 months ago by
.
-
- Topic
- Voices
- Posts
- Last Post
-
- Immunotherapy for hepatobiliary cancers: Emerging targets and translational adva
- 1
- 1
- 2 years, 4 months ago
- Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and
- 1
- 1
- 2 years, 4 months ago
- YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of
- 1
- 1
- 2 years, 4 months ago
- Molecular therapeutic targets for cholangiocarcinoma: Present challenges and fut
- 1
- 1
- 2 years, 4 months ago
- Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention
- 1
- 1
- 2 years, 4 months ago
- Immunotherapy for hepatobiliary cancers: Emerging targets and translational adva
- 1
- 1
- 2 years, 4 months ago
- MOLECULAR PROFILING IDENTIFIES TARGETABLE ALTERATIONS IN MAJORITY OF PATIENTS WI
- 1
- 1
- 2 years, 4 months ago
- Unraveling of genetic mechanism behind tumor formation may improve targeted trea
- 1
- 1
- 2 years, 4 months ago
- Epstein-Barr virus infection-associated cholangiocarcinoma: a report of one case
- 1
- 1
- 2 years, 4 months ago
- Associations between ultrasound screening findings and cholangiocarcinoma diagno
- 1
- 1
- 2 years, 4 months ago
- The role of insulin and incretin-based drugs in biliary tract cancer: epidemiolo
- 1
- 1
- 2 years, 4 months ago
- The forum ‘New Developments’ is closed to new topics and replies.